{"paper_id":"4b3089cf-a545-481a-8d0c-f321c1935fd8","body_text":"Utilizing network pharmacology, pharmacodynamics, molecular biology studies, and molecular docking techniques to uncover the mechanism of the Ligusticum wallichii-borneol medication combination for the treatment of ischemic stroke in rat models | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Utilizing network pharmacology, pharmacodynamics, molecular biology studies, and molecular docking techniques to uncover the mechanism of the Ligusticum wallichii-borneol medication combination for the treatment of ischemic stroke in rat models Pengfen He, Zhifeng Wang, Jiao Yang, pan Pan, Ting Shi, Shuangfeng Xu, and 6 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-5450540/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Objective .To use pharmacodynamics, molecular biology studies, network pharmacology, and molecular docking to study the mechanism of action of the Ligusticum wallichii (known as Chuanxiong in China, CX) and borneol (known as Bingpian in China, BP) medication pair (CXBP) for the treatment of ischemic stroke. Methods. The TCMSP, ETCM, and SymMap databases provided the effective chemical components and targets of CXBP, while the databases OMIM, GeneCards, TTD, Pubmed, Web of Science, CNKI, Wanfang Data, and VIP Database provided targets relevant to ischemic stroke. PPI network maps of important targets were created using the String database, and GO and KEGG enrichment analyses were carried out using the Metascape database. The \"Disease-Pathway-Target-Component-Drug\" network was constructed in Cytoscape, and Pymol and Autodock tools were used to confirm molecular docking. Rat models of MCAO was established, and neurological scores, TTC staining and Nissl's staining were performed. Finally, the key components were verified by enzyme-linked immunosorbent assay (ELISA), real-time fluorescence quantitative PCR, and immunohistochemistry. Results. There were 33 active ingredients and 419 potential targets in CXBP, involving the key active ingredients Z-6,8',7,3'-diligustilide, Cedrene,(+)- Alpha-Funebrene, POL, Dipterocarpol, Oleanolic acid, 1-Acetyl- beta-carboline, Erythrodiol, and the key targets were transcription factor ESR1, pro-inflammatory factor PRKCA, and anti-inflammatory factor PTPN6; KEGG pathway analysis enriched 179 signaling pathways, while the results of GO enrichment comprised 2911 biological processes, 398 molecular activities, and 203 cellular components. The neurological function score and TTC staining of the brain tissue infarct region were significantly lower following CXBP intervention compared to the MCAO group, which was corroborated by experimental evidence; Nissl's staining revealed that, following CXBP intervention, the cellular morphology was more intact and there were considerably more Nissl's vesicles in the infarcted area than in the MCAO group; By using ELISA, it was possible to see substantial changes in the expression levels of PRKCA, PTPN6, ESR1, and TNF-α as well as a considerable down-regulation of the levels of IL-1β, IL-6, and TNF-α as compared to the MCAO group. The expression levels of TNF-α, IL-6, and IL-1β were markedly downregulated; The PCR results indicated that, in comparison with the MCAO group, PRKCA significantly decreased, IL-1β, IL-6, and TNF-α expression levels were significantly down-regulated, and ESR1 and PTPN6 significantly increased. Immunohistochemistry revealed that, in comparison with the MCAO group, the CXBP group and the nimodipine group, had significantly higher ESR1 and PTPN6 expression levels and significantly lower PRKCA. Conclusions. In order to improve cerebral ischemia and reperfusion injury, CXBP may act through Z-6,8',7,3'-diligustilide, Cedrene,(+)-Alpha-Funebrene, POL, Dipterocarpol, Oleanolic acid, 1-Acetyl-beta-carboline, Erythrodiol, and other important active ingredients. CXBP acts on key targets ESR1, PRKCA, and PTPN6 to regulate multiple key signaling pathways. Ligusticum wallichii borneol ischemic stroke network pharmacology molecular docking experimental verification Full Text Additional Declarations No competing interests reported. Supplementary Files supplement1.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {\"props\":{\"pageProps\":{\"initialData\":{\"identity\":\"rs-5450540\",\"acceptedTermsAndConditions\":true,\"allowDirectSubmit\":true,\"archivedVersions\":[],\"articleType\":\"Research Article\",\"associatedPublications\":[],\"authors\":[{\"id\":384820532,\"identity\":\"ded1ff18-9cf0-47b4-942e-12336f49aacd\",\"order_by\":0,\"name\":\"Pengfen He\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Pengfen\",\"middleName\":\"\",\"lastName\":\"He\",\"suffix\":\"\"},{\"id\":384820533,\"identity\":\"19180027-6386-4b48-b549-089ea310f520\",\"order_by\":1,\"name\":\"Zhifeng Wang\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Zhifeng\",\"middleName\":\"\",\"lastName\":\"Wang\",\"suffix\":\"\"},{\"id\":384820534,\"identity\":\"2c0a1f6b-1fea-4f04-a05b-5b329784599f\",\"order_by\":2,\"name\":\"Jiao Yang\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The SecondClinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Jiao\",\"middleName\":\"\",\"lastName\":\"Yang\",\"suffix\":\"\"},{\"id\":384820535,\"identity\":\"a88b4cfe-92fa-4773-80f1-30d6a718a285\",\"order_by\":3,\"name\":\"pan Pan\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The SecondClinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"pan\",\"middleName\":\"\",\"lastName\":\"Pan\",\"suffix\":\"\"},{\"id\":384820536,\"identity\":\"a29af3fe-8b98-4f2f-9d9a-68eeae681481\",\"order_by\":4,\"name\":\"Ting Shi\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Ting\",\"middleName\":\"\",\"lastName\":\"Shi\",\"suffix\":\"\"},{\"id\":384820537,\"identity\":\"9fbe5dc1-1852-4e24-81f4-f89b23e719dd\",\"order_by\":5,\"name\":\"Shuangfeng Xu\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Shuangfeng\",\"middleName\":\"\",\"lastName\":\"Xu\",\"suffix\":\"\"},{\"id\":384820538,\"identity\":\"b97bdfae-f583-4237-821c-da4b1592d1df\",\"order_by\":6,\"name\":\"Junfeng Lan\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Junfeng\",\"middleName\":\"\",\"lastName\":\"Lan\",\"suffix\":\"\"},{\"id\":384820539,\"identity\":\"1282396d-cf88-4607-9d69-4accb6adccf3\",\"order_by\":7,\"name\":\"Zhihui Hao\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Zhihui\",\"middleName\":\"\",\"lastName\":\"Hao\",\"suffix\":\"\"},{\"id\":384820540,\"identity\":\"a8752878-5508-4f08-ac55-68c465839863\",\"order_by\":8,\"name\":\"Aiming Yang\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"Yunnan Provincial Hospital of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Aiming\",\"middleName\":\"\",\"lastName\":\"Yang\",\"suffix\":\"\"},{\"id\":384820541,\"identity\":\"364c61c2-4fcd-4569-8052-2ffc8dd5326a\",\"order_by\":9,\"name\":\"Liang Chen\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Liang\",\"middleName\":\"\",\"lastName\":\"Chen\",\"suffix\":\"\"},{\"id\":384820542,\"identity\":\"4a7ed8bf-9bd8-42f6-a6d3-aacdbd3f94a0\",\"order_by\":10,\"name\":\"Yujiang Xi\",\"email\":\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAvUlEQVRIiWNgGAWjYBACeYbDBw5++CFhJ8/eQKQWw8ZjiYcle2ySDXsOEGvN4TPGB3jY0hgbbiQQqYOx7YDBAQmew8yMMx9vvMFQYxNNUAs7z4GEAwUWh/nYpdOKLRiOpeU2ELRlxoEDEFtm55hJMDYcJqyF4f7DBqBfDjM23DxDrJYDhxmg3uchUothwzEGaCAD/ZJAjF/kGc5//giJysMbb3yosSHCYUjAQCKBFOUQLaTqGAWjYBSMgpEBABi+Rnm7/xmUAAAAAElFTkSuQmCC\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":true,\"prefix\":\"\",\"firstName\":\"Yujiang\",\"middleName\":\"\",\"lastName\":\"Xi\",\"suffix\":\"\"},{\"id\":384820543,\"identity\":\"6a4be45b-4a41-4ec7-92f5-faf10e646d08\",\"order_by\":11,\"name\":\"Jian Wang\",\"email\":\"\",\"orcid\":\"\",\"institution\":\"The First Clinical College of Yunnan University of Chinese Medicine\",\"correspondingAuthor\":false,\"prefix\":\"\",\"firstName\":\"Jian\",\"middleName\":\"\",\"lastName\":\"Wang\",\"suffix\":\"\"}],\"badges\":[],\"createdAt\":\"2024-11-14 03:23:32\",\"currentVersionCode\":1,\"declarations\":\"\",\"doi\":\"10.21203/rs.3.rs-5450540/v1\",\"doiUrl\":\"https://doi.org/10.21203/rs.3.rs-5450540/v1\",\"draftVersion\":[],\"editorialEvents\":[],\"editorialNote\":\"\",\"failedWorkflow\":false,\"files\":[{\"id\":76243591,\"identity\":\"edb251bd-db12-42d9-b751-f6a4fd585b5a\",\"added_by\":\"auto\",\"created_at\":\"2025-02-14 01:16:34\",\"extension\":\"pdf\",\"order_by\":1,\"title\":\"\",\"display\":\"\",\"copyAsset\":false,\"role\":\"manuscript-pdf\",\"size\":1728117,\"visible\":true,\"origin\":\"\",\"legend\":\"\",\"description\":\"\",\"filename\":\"manuscript.pdf\",\"url\":\"https://assets-eu.researchsquare.com/files/rs-5450540/v1_covered_5bb3f6df-c2d6-4069-9286-063bf6b2c1a8.pdf\"},{\"id\":71654398,\"identity\":\"fa6b9710-3053-498a-a112-3eb84005965a\",\"added_by\":\"auto\",\"created_at\":\"2024-12-17 12:41:22\",\"extension\":\"docx\",\"order_by\":26,\"title\":\"\",\"display\":\"\",\"copyAsset\":false,\"role\":\"supplement\",\"size\":26890,\"visible\":true,\"origin\":\"\",\"legend\":\"\",\"description\":\"\",\"filename\":\"supplement1.docx\",\"url\":\"https://assets-eu.researchsquare.com/files/rs-5450540/v1/7fded9b597cd444c506f4cbe.docx\"}],\"financialInterests\":\"No competing interests reported.\",\"formattedTitle\":\"Utilizing network pharmacology, pharmacodynamics, molecular biology studies, and molecular docking techniques to uncover the mechanism of the Ligusticum wallichii-borneol medication combination for the treatment of ischemic stroke in rat models\",\"fulltext\":[],\"fulltextSource\":\"\",\"fullText\":\"\",\"funders\":[],\"hasAdminPriorityOnWorkflow\":false,\"hasManuscriptDocX\":false,\"hasOptedInToPreprint\":true,\"hasPassedJournalQc\":\"\",\"hasAnyPriority\":false,\"hideJournal\":true,\"highlight\":\"\",\"institution\":\"\",\"isAcceptedByJournal\":false,\"isAuthorSuppliedPdf\":true,\"isDeskRejected\":\"\",\"isHiddenFromSearch\":false,\"isInQc\":false,\"isInWorkflow\":false,\"isPdf\":true,\"isPdfUpToDate\":true,\"isWithdrawnOrRetracted\":false,\"journal\":{\"display\":true,\"email\":\"info@researchsquare.com\",\"identity\":\"researchsquare\",\"isNatureJournal\":false,\"hasQc\":true,\"allowDirectSubmit\":true,\"externalIdentity\":\"\",\"sideBox\":\"\",\"snPcode\":\"\",\"submissionUrl\":\"/submission\",\"title\":\"Research Square\",\"twitterHandle\":\"researchsquare\",\"acdcEnabled\":true,\"dfaEnabled\":false,\"editorialSystem\":\"\",\"reportingPortfolio\":\"\",\"inReviewEnabled\":false,\"inReviewRevisionsEnabled\":true},\"keywords\":\"Ligusticum wallichii, borneol, ischemic stroke, network pharmacology, molecular docking, experimental verification\",\"lastPublishedDoi\":\"10.21203/rs.3.rs-5450540/v1\",\"lastPublishedDoiUrl\":\"https://doi.org/10.21203/rs.3.rs-5450540/v1\",\"license\":{\"name\":\"CC BY 4.0\",\"url\":\"https://creativecommons.org/licenses/by/4.0/\"},\"manuscriptAbstract\":\"\\u003cp\\u003e\\u003cem\\u003e\\u003cstrong\\u003eObjective\\u003c/strong\\u003e\\u003c/em\\u003e.To use pharmacodynamics, molecular biology studies, network pharmacology, and molecular docking to study the mechanism of action of the Ligusticum wallichii (known as Chuanxiong in China, CX) and borneol (known as Bingpian in China, BP) medication pair (CXBP) for the treatment of ischemic stroke.\\u0026nbsp;\\u003c/p\\u003e\\n\\u003cp\\u003e\\u003cem\\u003e\\u003cstrong\\u003eMethods.\\u003c/strong\\u003e\\u003c/em\\u003e The TCMSP, ETCM, and SymMap databases provided the effective chemical components and targets of CXBP, while the databases OMIM, GeneCards, TTD, Pubmed, Web of Science, CNKI, Wanfang Data, and VIP Database provided targets relevant to ischemic stroke. PPI network maps of important targets were created using the String database, and GO and KEGG enrichment analyses were carried out using the Metascape database. The \\\"Disease-Pathway-Target-Component-Drug\\\" network was constructed in Cytoscape, and Pymol and Autodock tools were used to confirm molecular docking. Rat models of MCAO was established, and neurological scores, TTC staining and Nissl's staining were performed. Finally, the key components were verified by enzyme-linked immunosorbent assay (ELISA), real-time fluorescence quantitative PCR, and immunohistochemistry.\\u0026nbsp;\\u003c/p\\u003e\\n\\u003cp\\u003e\\u003cem\\u003e\\u003cstrong\\u003eResults.\\u003c/strong\\u003e\\u003c/em\\u003eThere were 33 active ingredients and 419 potential targets in CXBP, involving the key active ingredients Z-6,8',7,3'-diligustilide, Cedrene,(+)- Alpha-Funebrene, POL, Dipterocarpol, Oleanolic acid, 1-Acetyl- beta-carboline, Erythrodiol, and the key targets were transcription factor ESR1, pro-inflammatory factor PRKCA, and anti-inflammatory factor PTPN6; KEGG pathway analysis enriched 179 signaling pathways, while the results of GO enrichment comprised 2911 biological processes, 398 molecular activities, and 203 cellular components. The neurological function score and TTC staining of the brain tissue infarct region were significantly lower following CXBP intervention compared to the MCAO group, which was corroborated by experimental evidence; Nissl's \\u0026nbsp;staining revealed that, following CXBP intervention, the cellular morphology was more intact and there were considerably more Nissl's \\u0026nbsp;vesicles in the infarcted area than in the MCAO group; By using ELISA, it was possible to see substantial changes in the expression levels of PRKCA, PTPN6, ESR1, and TNF-α as well as a considerable down-regulation of the levels of IL-1β, IL-6, and TNF-α as compared to the MCAO group. The expression levels of TNF-α, IL-6, and IL-1β were markedly downregulated; The PCR results indicated that, in comparison with the MCAO group, PRKCA significantly decreased, IL-1β, IL-6, and TNF-α expression levels were significantly down-regulated, and ESR1 and PTPN6 significantly increased. Immunohistochemistry revealed that, in comparison with the MCAO group, the CXBP group and the nimodipine group, had significantly higher ESR1 and PTPN6 expression levels and significantly lower PRKCA.\\u0026nbsp;\\u003c/p\\u003e\\n\\u003cp\\u003e\\u003cem\\u003e\\u003cstrong\\u003eConclusions.\\u003c/strong\\u003e\\u003c/em\\u003eIn order to improve cerebral ischemia and reperfusion injury, CXBP may act through Z-6,8',7,3'-diligustilide, Cedrene,(+)-Alpha-Funebrene, POL, Dipterocarpol, Oleanolic acid, 1-Acetyl-beta-carboline, Erythrodiol, and other important active ingredients. CXBP acts on key targets ESR1, PRKCA, and PTPN6 to regulate multiple key signaling pathways.\\u003c/p\\u003e\",\"manuscriptTitle\":\"Utilizing network pharmacology, pharmacodynamics, molecular biology studies, and molecular docking techniques to uncover the mechanism of the Ligusticum wallichii-borneol medication combination for the treatment of ischemic stroke in rat models\",\"msid\":\"\",\"msnumber\":\"\",\"nonDraftVersions\":[{\"code\":1,\"date\":\"2024-12-17 12:41:17\",\"doi\":\"10.21203/rs.3.rs-5450540/v1\",\"editorialEvents\":[{\"type\":\"communityComments\",\"content\":0}],\"status\":\"published\",\"journal\":{\"display\":true,\"email\":\"info@researchsquare.com\",\"identity\":\"researchsquare\",\"isNatureJournal\":false,\"hasQc\":true,\"allowDirectSubmit\":true,\"externalIdentity\":\"\",\"sideBox\":\"\",\"snPcode\":\"\",\"submissionUrl\":\"/submission\",\"title\":\"Research Square\",\"twitterHandle\":\"researchsquare\",\"acdcEnabled\":true,\"dfaEnabled\":false,\"editorialSystem\":\"\",\"reportingPortfolio\":\"\",\"inReviewEnabled\":false,\"inReviewRevisionsEnabled\":true}}],\"origin\":\"\",\"ownerIdentity\":\"312a14dc-a61f-4bea-8224-215544c83010\",\"owner\":[],\"postedDate\":\"December 17th, 2024\",\"published\":true,\"recentEditorialEvents\":[],\"rejectedJournal\":[],\"revision\":\"\",\"amendment\":\"\",\"status\":\"posted\",\"subjectAreas\":[],\"tags\":[],\"updatedAt\":\"2025-02-14T01:08:16+00:00\",\"versionOfRecord\":[],\"versionCreatedAt\":\"2024-12-17 12:41:17\",\"video\":\"\",\"vorDoi\":\"\",\"vorDoiUrl\":\"\",\"workflowStages\":[]},\"version\":\"v1\",\"identity\":\"rs-5450540\",\"journalConfig\":\"researchsquare\"},\"__N_SSP\":true},\"page\":\"/article/[identity]/[[...version]]\",\"query\":{\"redirect\":\"/article/rs-5450540\",\"identity\":\"rs-5450540\",\"version\":[\"v1\"]},\"buildId\":\"qtupq5eGEP_6zYnWcrvyt\",\"isFallback\":false,\"isExperimentalCompile\":false,\"dynamicIds\":[84888],\"gssp\":true,\"scriptLoader\":[]}","source_license":"CC-BY-4.0","license_restricted":false}